Related Experiment Video
Updated: Jan 15, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Targeted antimicrobial use admission provides an actionable denominator for evaluating inpatient length of therapy
April Dyer1,2, Elizabeth Dodds-Ashley1,2, Angelina Davis1,2
1Duke Center for Antimicrobial Stewardship and Infection Prevention, Durham, NC, USA.
Abstract:
Our novel antibiotic use denominator, targeted antimicrobial use admission, is defined as an inpatient admission in which a select agent or group of agents is administered. Used in combination with length of therapy, it allows programs to quickly assess agent inpatient durations.
More Related Videos
09:59Application of the Intelligent High-Throughput Antimicrobial Sensitivity Testing/Phage Screening System and Lar Index of Antimicrobial Resistance
Published on: July 21, 2023
06:18A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Related Concept Videos
Antimicrobial Effectiveness
Dosage Interval and Administration Route: Determination Methods
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Therapeutic Drug Monitoring: Overview and Classification
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Acute Pyelonephritis II: Diagnostic Studies and Management